Mr Bains has more than two decades of experience in the global pharmaceutical space
Biotechnology major Biocon's custom research arm Syngene has appointed Mr Peter Bains as its Chief executive Officer (CEO).
"Company's Subsidiary Syngene International (Syngene) has appointed Peter Bains, Director, as the CEO of Syngene," the company said in a filing to BSE.
Mr Bains has more than two decades of experience in the global pharmaceutical space.
There has been reports that Biocon would file a prospectus for listing Syngene soon.